Pharming Group (CHIX:PHARMa)
€ 0.7515 0 (0%) Market Cap: 501.38 Mil Enterprise Value: 468.90 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 81/100

Q4 2020 Pharming Group NV Earnings Call Transcript

Mar 04, 2021 / 12:30PM GMT
Release Date Price: €1.12
Sijmen de Vries
Pharming Group N.V. - Executive Director & CEO

Good afternoon, ladies and gentlemen, and welcome to the full year results conference call -- full year results 2020 conference call.

Before I go into this, I would like to point you to the slide that says forward-looking statements as this presentation may contain some forward-looking statements, including statements about our beliefs and expectations that are based on our current plans, estimates and projections, as well as our expectations of external conditions and events.

And after doing this, I would like to have the honor to introduce my new colleague, Jeroen Wakkerman, our new CFO, who joined us from, what is it, 16th of November. So he's very fresh still to the company, and who's sitting here next to me. And I'm very pleased Jeroen joined us. And I would like to hand over to you, Jeroen, to provide us with the financial highlights.

Jeroen Wakkerman
Pharming Group N.V. - CFO

Yes. Thank you very much, Sijmen. Maybe first a bit about why I joined Pharming at this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot